


Visit us at L003
Innovation and integration enable QuarkBio to deliver accessible solution for customer success


Oncogenic Druggable Fusion
First line screening for possible fusion-targeted therapy


Indeterminate
Thyroid Nodule Cytology

Solution: Risk stratification through fast, affordable molecular analysis

Insight to Action

Transform your research into clinical-actionable product


NextAmp™
Analysis System

A dual-functioning system capable of multi-biomarker analysis and digital detection of low quantity genes

Innovation through Collaborations
We collaborate for your success by customizing smarter and more suitable biomarker solution to meet your clinical needs

High Tolerance for Sample Quality
Our assays enable more patients to receive suitable drug treatments with the ability to analyze poor quality and low concentration samples

Pinpoint Eligible Patients
PanelChip® offers a cost-effective platform for large scale screening of patient with rare gene rearrangements

Proven Clinical Utility with Expression Biomarkers
Translating discoveries into products, we have helped multiple companies develop mRNA- and miRNA-based assay
What We Do
Simple to use cancer panels for actionable mutations and diagnosis
Why QuarkBio?
Latest News

Events
Healthcare Expo | Taiwan
CONFERENCE
Exhibition: Sep 01 – 04, 2022
Location: Taipei Nangang Exhibition Center, Hall 1, 1、4F (L003)
MEDICA 2022 | Düsseldorf, Germany
CONFERENCE
Exhibition: Nov 14 – 17, 2022
Location: D-40474 Düsseldorf, Am Staad (Stockumer Höfe)